Moreover, survival analysis conducted using the Kaplan–Meier plotter, which relied on RNA-seq data, further substantiated that elevated CD47 expression in individuals diagnosed with stomach adenocarcinoma generally indicated a diminished likelihood of relapse-free survival (Fig. 1H). Here, CD47 is linked to gastric adenocarcinoma.